AAGBI guidelines: the use of blood components and their alternatives 2016

Anaesthesia

Volumn 71, Issue 7, 2016, Pages 829-842

  Klein, A A ^a   Arnold, P ^b   Bingham, R M ^c   Brohi, K ^d   Clark, R ^e   Collis, R ^f   Gill, R ^g   McSporran, W ^h   Moor, P ⁱ   Rao Baikady, R ^h   Richards, T ^j   Shinde, S ^k   Stanworth, S ^l   Walsh, T S ^m  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ DERRIFORD HOSPITAL   (United Kingdom)

^j UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^k SOUTHMEAD HOSPITAL   (United Kingdom)

^l OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

anaemia and coagulation; blood crossmatch; FFP indications; major haemorrhage; transfusion

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEMOGLOBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ANEMIA; ANESTHESIST; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; COLLOID; CORONARY STENT; CRYOPRECIPITATE; CRYSTALLOID; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HUMAN; HYPOTENSION; INJURY; INTENSIVE CARE; LABORATORY TEST; MEDICAL SOCIETY; OBSTETRICS; PEDIATRICS; POINT OF CARE TESTING; PRACTICE GUIDELINE; RESUSCITATION;

EID: 84990214218     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13489     Document Type: Article

References (44)

1. Bolton-Maggs PHB, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. British Journal of Haematology 2013; 163: 303–14.
2. NHS Blood and Transplant. Patient Blood Management: Optimising the Care of Patients who may need Transfusion. http://hospital.blood.co.uk/media/27420/140804-1-25447-bookmark-patient-blood-management.pdf (accessed 08/11/2015).
3. Clevenger B, Mallett SV, Klein AA, Richards T. Patient blood management to reduce surgical risk. British Journal of Surgery 2015; 102: 1325–37.
4. Kotzé A, Harris A, Baker C, et al. British Committee for Standards in Haematology Guidelines on the identification and management of pre-operative anaemia. British Journal of Haematology 2015; 171: 322–31.
5. Clevenger B, Richards T. Pre-operative anaemia. Anaesthesia 2015; 70: 20–e8.
6. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. British Journal of Anaesthesia 2010; 105: 401–16.
7. National Patient Safety Agency. Safer Practice Notice 14: Right patient, right blood. October 2006. NPSA/2006/14. http://www.nrls.npsa.nhs.uk/resources/clinical-specialty/emergency-medicine/?Entryid45=59805 (accessed 08/11/2015).
8. Medicines and Healthcare Products Regulatory Authority. Blood Safety and Quality Regulations, 2005. http://www.shotuk.org/wp-content/uploads/2010/03/12-David-Churchward.pdf (accessed 08/11/2015).
9. Advisory Committee on the Safety of Blood, Tissues and Organs (sabto). Patient Consent for Blood Transfusion, 2011. https://www.gov.uk/government/publications/patient-consent-for-blood-transfusion (accessed 01/12/2015).
10. British Committee for Standards in Haematology Guidelines on the Administration of Blood Components, 2009. http://www.bcshguidelines.com/documents/Admin_blood_components_bcsh_05012010.pdf (accessed 08/11/2015).
11. Tinegate H, Birchall J, Gray A, et al. British Committee for Standards in Haematology. Blood Transfusion Task Force Guideline on the investigation and management of acute transfusion reactions. British Journal of Haematology 2012; 159: 143–53.
12. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. American Journal of Medicine 2014; 127: 124–31.
13. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. British Medical Journal 2015; 350: h1354.
14. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. New England Journal of Medicine 2015; 372: 997–1008.
15. British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage, 2015. Http://www.bcshguidelines.com/documents/Major_Haemorrhage.pdf (accessed 08/11/2015).
16. Gill R. Practical management of major blood loss. Anaesthesia 2015; 70: 54–e20.
17. Retter A, Barrett NA. The management of abnormal haemostasis in the ICU. Anaesthesia 2015; 70: 121–e41.
18. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. British Journal of Haematology 2013; 160: 445–64.
19. Lilley G, Burkett-St-Laurent D, Precious E, et al. Measurement of blood loss during postpartum haemorrhage. International Journal of Obstetetric Anesthesia 2015; 24: 8–14.
20. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia 2015; 70: 78–e28.
21. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015; 70: 166–75.
22. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014; 124: 1727–36.
23. Kirpalani H, Whyte RK, Anderson C, et al. The premature infants in need of transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. Journal of Pediatrics 2006; 149: 301–7.
24. New HV, Grant-Casey J, Lowe D, Kelleher A, Hennem S, Stanworth SJ. Red blood cell transfusion practice in children: current status and areas for improvement? A study of the use of red blood cell transfusions in children and infants. Transfusion 2014; 54: 119–27.
25. Royal College of Paediatrics and Chuild Health. Major trauma and the use of tranexamic acid in children, 2012. Http://www.rcpch.ac.uk/system/files/protected/page/Major Trauma and the Use of Tranexamic Acid in Children - Evidence Statement 2012-11.pdf (accessed 08/11/2015).
26. Cholette JM, Powers KS, Alfieris GM, et al. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatric Critical Care Medicine 2013; 14: 137–47.
27. Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anaesthesia 2015; 70: 96–e34.
28. Hall S, Murphy MF. Limitations of component therapy for massive haemorrhage: is whole blood the whole solution? Anaesthesia 2015; 70: 511–4.
29. Klein AA, Collier TJ, Brar MS, et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK - the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 2016; 71: 627–35.
30. National Institute for Health and Care Excellence (NICE). Viscoelastic Point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. https://www.nice.org.uk/guidance/dg13/documents/detecting-managing-and-monitoring-haemostasis-viscoelastometric-pointofcare-testing-rotem-teg-and-sonoclot-systems-diagnostics-assessment-report2 (accessed 08/11/2015).
31. Besser MW, Ortmann E, Klein AA. Haemostatic management of cardiac surgical haemorrhage. Anaesthesia 2015; 70: 87–e31.
32. Corredor C, Wasowicz M, Karkouti K, Sharma V. The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis. Anaesthesia 2015; 70: 715–31.
33. Fowler A, Perry DJ. Laboratory monitoring of haemostasis. Anaesthesia 2015; 70: 68–e24.
34. Mallett SV, Armstrong M. Point-of-care monitoring of haemostasis. Anaesthesia 2015; 70: 73–e26.
35. ® and laboratory haemoglobin measurements in obstetric patients. Anaesthesia 2013; 68: 40–5.
36. Hildyard C, Curry N. Point-of-care testing: a standard of care? Anaesthesia 2015; 70: 1113–8.
37. Quarterman C, Shaw M, Johnson I, Agarwal S. Intra- and inter-centre standardisation of thromboelastography (TEG). Anaesthesia 2014; 69: 883–90.
38. Van Veen JJ, Makris M. Management of peri-operative anti-thrombotic therapy. Anaesthesia 2015; 70: 58–e23.
39. Sharma V, Katznelson R, Jerath A, et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 2014; 69: 124–30.
40. Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia 2015; 70: 50–e18.
41. Ortmann E, Besser MW, Klein AA. Antifibrinolytic agents in current anaesthetic practice. British Journal of Anaesthesia 2013; 111: 549–63.
42. Challis M, Marrin C, Vaughan RS, Goringe A. Who requires irradiated blood products? Anaesthesia 2011; 66: 620–1.
43. Hart S, Cserti-Gazdewich CM, McCluskey SA. Red cell transfusion and the immune system. Anaesthesia 2015; 70: 38–e16.
44. Gill R, Herbertson M, Vuylsteke A, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21–7.